e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Asthma and COPD: understanding through monitoring
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma
C. Thamrin, R. Nydegger, G. Stern, P. Chanez, S. Wenzel, S. Fitzpatrick, R. Watt, R. Taylor, U. Frey (Switzerland; Marseille, France; Pittsburgh, Malvern, United States Of America; Dunedin, New Zealand)
Source:
Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Session:
Asthma and COPD: understanding through monitoring
Session type:
Oral Presentation
Number:
402
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Thamrin, R. Nydegger, G. Stern, P. Chanez, S. Wenzel, S. Fitzpatrick, R. Watt, R. Taylor, U. Frey (Switzerland; Marseille, France; Pittsburgh, Malvern, United States Of America; Dunedin, New Zealand). Fluctuations in lung function vs. asthma control, exacerbations and severity: An alternate look at phenotyping asthma. Eur Respir J 2010; 36: Suppl. 54, 402
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
COPD: An outcome of childhood asthma?
Source: Annual Congress 2010 - Functional assessment of paediatric lung disease
Year: 2010
Fluctuations in airway function: chronic asthma seen as a complex dynamic system
Source: Annual Congress 2006 - Physiological year in review
Year: 2006
Difficulty in management of COPD exacerbation: Is this chronic exacerbation or difficult COPD: “A specific phenotype?”
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
The evaluation and biomarkers of severe asthma
Source: Annual Congress 2010 - Severe asthma: reviewing the last decade and looking to the next. A report of the ERS/ATS Task Force
Year: 2010
Mechanisms in asthma and COPD: different but increasingly similar
Source: Annual Congress 2010 - Similarities and differences between asthma and COPD: the "Dutch Hypothesis" revisited
Year: 2010
What can we learn from models to study exacerbation mechanisms in asthma and COPD?
Source: Annual Congress 2010 - Severe exacerbations in asthma and COPD: new causes, mechanisms and models of care
Year: 2010
Does lung function change in the months after an asthma exacerbation in children?
Source: Virtual Congress 2021 – Paediatric asthma and bronchopulmonary dysplasia
Year: 2021
Omalizumab therapy reduces asthma exacerbations in children with severe allergic (IgE-mediated) asthma irrespective of lung function at baseline
Source: Annual Congress 2009 - Difficult asthma in children: diagnostic and therapeutic challenges
Year: 2009
Severe exacerbations predict excess lung function decline in asthma
Source: Eur Respir J 2007; 30: 452-456
Year: 2007
Clinical control of asthma associated with measures of airway inflammation
Source: Annual Congress 2010 - Asthma and COPD: understanding through monitoring
Year: 2010
Effect of indacaterol/glycopyrronium (IND/GLY) vs salmeterol/fluticasone (SFC) on moderate or severe COPD exacerbations and lung function based on baseline blood eosinophil counts: Results from the FLAME study
Source: International Congress 2016 – Pharmacological management of COPD
Year: 2016
Emergency visits for asthma: asthma exacerbations or poor asthma control?
Source: Eur Respir J 2004; 24: Suppl. 48, 598s
Year: 2004
Asthma phenotypes: do cough and wheeze predict exacerbations in persistent asthma?
Source: Eur Respir J, 50 (6) 1701366; 10.1183/13993003.01366-2017
Year: 2017
Relationship between depression and exacerbations in COPD: a response
Source: Eur Respir J 2008; 32: 1126-1127
Year: 2008
COPD exacerbation: Influence of severity and type of systemic inflammation on the hospitalizations rate
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
Relationship between benralizumab exposure and asthma exacerbation rate for patients with severe asthma
Source: International Congress 2017 – Asthma: mechanisms and treatment
Year: 2017
Predicting exacerbations: asthma, allergy and exhaled NO
Source: Annual Congress 2009 - Clinical aspects of inflammatory airways diseases
Year: 2009
COPD: problems in diagnosis and measurement
Source: Eur Respir J 2003; 21: 4S-12S
Year: 2003
Blood eosinophils, exacerbations in the previous year, lung function and ICS dose predict frequent exacerbations in asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept